Rovner Barry W
Jefferson Medical College, Philadelphia, Pennsylvania, USA.
Curr Opin Ophthalmol. 2006 Jun;17(3):275-7. doi: 10.1097/01.icu.0000193100.13551.ac.
The Charles Bonnet syndrome is a disorder of visual hallucinations typically occurring in older persons with vision impairment or deafferentation of the visual cortex. This review cites recent studies on Charles Bonnet syndrome and discusses treatment options. The numbers of affected persons will increase with aging of the population, making recognition and treatment important components of ophthalmologic care.
The etiology of the Charles Bonnet syndrome is varied; most often it involves direct damage to the visual system (e.g. age-related macular degeneration, glaucoma) but it may also result from cerebral pathology interrupting connections between the eye and the occipital cortex. Case reports of different management approaches demonstrate the range of treatment options.
This review suggests that the Charles Bonnet syndrome will affect an increasingly large number of older persons as the population ages and the occurrence of vision and cerebral disorders increases. Clinical trials of antipsychotic and other medications, as well as low-vision rehabilitation, are necessary to establish valid treatments for this disorder.
查尔斯·邦尼特综合征是一种视幻觉障碍,通常发生于视力受损或视觉皮层传入神经阻滞的老年人。本综述引用了关于查尔斯·邦尼特综合征的最新研究并讨论了治疗方案。随着人口老龄化,患病人数将会增加,因此识别和治疗是眼科护理的重要组成部分。
查尔斯·邦尼特综合征的病因多种多样;最常见的是涉及视觉系统的直接损伤(如年龄相关性黄斑变性、青光眼),但也可能由中断眼与枕叶皮层之间联系的脑部病变引起。不同管理方法的病例报告展示了治疗方案的范围。
本综述表明,随着人口老龄化以及视力和脑部疾病发生率的增加,查尔斯·邦尼特综合征将影响越来越多的老年人。有必要开展抗精神病药物和其他药物的临床试验以及低视力康复治疗,以确立针对该疾病的有效治疗方法。